This post was originally published on this site
Favorable government regulations, coupled with the introduction of new and sophisticated products, and growing demand for synthetic biology, should keep driving the biotech industry’s growth. Indeed, the global biotechnology market is expected to reach $2.44 trillion in 2028, growing at a 15.8% CAGR.
Considering the industry’s promising growth prospects, we believe shares of biotechnology companies Genmab A/S (GMAB) and Bio-Techne Corporation (TECH) are well-positioned to deliver exceptional returns in the coming months. So, these stocks could be wise bets now.
